Embecta (EMBC) Depreciation & Amortization (CF) (2020 - 2026)
Embecta (EMBC) reported Depreciation & Amortization (CF) of $10.2 million for Q1 2026, up 13.33% on a YoY basis from $9.0 million in Q1 2025, and down 0.97% sequentially from $10.3 million in Q4 2025.
Embecta (EMBC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Embecta (EMBC) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $10.2 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 13.33% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $42.8 million (up 16.3% YoY), and the FY2025 full-year result was $40.7 million, up 12.43% from the prior year.
- Depreciation & Amortization (CF) fell to $10.2 million in Q1 2026, from $10.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $13.1 million in Q3 2025 to a low of $6.7 million in Q1 2022.
- A 5-year average of $9.0 million and a median of $9.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) sank 34.31% in 2022 and surged 37.89% in 2025, its largest moves.
- Tracing EMBC's Depreciation & Amortization (CF) over 5 years: stood at $7.2 million in 2022, then rose by 22.22% to $8.8 million in 2023, then gained by 6.82% to $9.4 million in 2024, then advanced by 9.57% to $10.3 million in 2025, then retreated by 0.97% to $10.2 million in 2026.
- Business Quant data shows EMBC's Depreciation & Amortization (CF) at $10.2 million in Q1 2026, $10.3 million in Q4 2025, and $13.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.20 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 13.10 Mn |
| Sep 30, 2025 | 13.10 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 8.80 Mn |
| Dec 31, 2023 | 8.80 Mn |